Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study.
Bernard MC, Waldock J, Commandeur S, Strauß L, Trombetta CM, Marchi S, Zhou F, van de Witte S, van Amsterdam P, Ho S, Hoschler K, Lugovtsev V, Weir JP, Montomoli E, Cox RJ, Engelhardt OG, Friel D, Wagner R, Ollinger T, Germain S, Sediri-Schön H. Bernard MC, et al. Among authors: van de witte s. Front Immunol. 2022 Jun 17;13:909297. doi: 10.3389/fimmu.2022.909297. eCollection 2022. Front Immunol. 2022. PMID: 35784305 Free PMC article.
A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses.
van de Witte S, Nauta J, Montomoli E, Weckx J. van de Witte S, et al. Vaccine. 2018 Sep 25;36(40):6030-6038. doi: 10.1016/j.vaccine.2018.04.043. Epub 2018 Apr 27. Vaccine. 2018. PMID: 29709447 Free article. Clinical Trial.
Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study.
Basu I, Agarwal M, Shah V, Shukla V, Naik S, Supe PD, Srivastava MK, Giriraja KV, Pinjar P, Mishra PK, Joshi S, Vijayakumar R, van de Witte S. Basu I, et al. Among authors: van de witte s. Hum Vaccin Immunother. 2022 Dec 31;18(1):1-10. doi: 10.1080/21645515.2021.1885278. Epub 2021 May 6. Hum Vaccin Immunother. 2022. PMID: 33957854 Free PMC article. Clinical Trial.
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India.
Kalappanavar NK, Ghosh A, Sharma M, Ravichandran L, Choraria N, P S, Pandey M, N P, Shah P, Nair S, Shaikh A, van de Witte S. Kalappanavar NK, et al. Among authors: van de witte s. Hum Vaccin Immunother. 2022 Nov 30;18(6):2104527. doi: 10.1080/21645515.2022.2104527. Epub 2022 Sep 2. Hum Vaccin Immunother. 2022. PMID: 36053721 Free PMC article. Clinical Trial.
Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial.
Rascol O, Bronzova J, Hauser RA, Lang AE, Sampaio C, Theeuwes A, van de Witte SV. Rascol O, et al. Among authors: van de witte sv. Parkinsonism Relat Disord. 2012 May;18(4):370-6. doi: 10.1016/j.parkreldis.2011.12.006. Epub 2012 Feb 7. Parkinsonism Relat Disord. 2012. PMID: 22316635 Clinical Trial.
19 results